Texas Secures $7.5 Million Settlement with Tris Pharma Over Pediatric ADHD Drug Marketing
State prosecutors finalized a resolution concluding allegations that the pharmaceutical manufacturer misled Medicaid providers regarding how quickly an ADHD medication acted for pediatric patients.























